| Literature DB >> 24382849 |
David Laszlo Tarnoki1, Adam Domonkos Tarnoki, Levente Littvay, Pal Bata, Viktor Berczi, Zsolt Garami, Kinga Karlinger.
Abstract
AIM: To estimate heritability and environmental effects on renal parenchymal thickness.Entities:
Mesh:
Year: 2013 PMID: 24382849 PMCID: PMC3914463 DOI: 10.3325/cmj.2013.54.550
Source DB: PubMed Journal: Croat Med J ISSN: 0353-9504 Impact factor: 1.351
Figure 1Univariate additive genetic (A), common environmental (C), and unique environmental (E) influences analysis of renal parenchymal thickness (RPT). Rectangles denote the observed variables (right and left RPT) and circles denote the latent variables of A, C and E. Curved arrows denote correlations (fixed at the highlighted values). Straight arrows signify the estimated impact of the latent factor on the variance of the observed phenotype.
Clinical and ultrasonographic characteristics according to zygosity
| Total | Zygosity | ||
|---|---|---|---|
| monozygotic | dizygotic | ||
| Participants, n | 196 | 136 | 60 |
| Women:men ratio | 150:46 | 104:32 | 46:14 |
| Age, years (meanƒ?%¶+ƒ?%standard deviation) | 44.2ƒ?%¶+ƒ?%16.7 | 42.3ƒ?%¶+ƒ?%16.9ƒ? | 48.5ƒ?%¶+ƒ?%15.5ƒ? |
| Hypertension*, n (%) | 62 (31.6) | 44 (32.4) | 18 (30.0) |
| Diabetesƒ?ó, n (%) | 10 (5.1) | 9 (6.6) | 1 (1.7) |
| Hyperlipidemia¶õ, n (%) | 44 (22.4) | 27 (19.9) | 17 (28.3) |
| Body mass index, kg/m2 (meanƒ?%¶+ƒ?%standard deviation) | 25.7ƒ?%¶+ƒ?%4.9 | 25.6ƒ?%¶+ƒ?%5.0 | 25.9ƒ?%¶+ƒ?%4.7 |
| Current smokers, n (%) | 27 (13.8) | 19 (14.0) | 8 (13.3) |
| Stroke, n | 4 (2.0) | 4 (2.9) | 0 (0.0) |
| Myocardial infarction, n (%) | 7 (3.6) | 5 (3.7) | 2 (3.3) |
| Mean right renal parenchymal thickness, cm (meanƒ?%¶+ƒ?%standard deviation) | 1.32ƒ?%¶+ƒ?%0.33 | 1.32ƒ?%¶+ƒ?%0.32 | 1.33ƒ?%¶+ƒ?%0.33 |
| Mean left renal parenchymal thickness, cm (meanƒ?%¶+ƒ?%standard deviation) | 1.62ƒ?%¶+ƒ?%0.31 | 1.60ƒ?%¶+ƒ?%0.33 | 1.67ƒ?%¶+ƒ?%0.30 |
*Defined according to the clinical history and patients on anti-hypertensive medication.
ƒ? Pƒ?%<ƒ?%0.05 vs dizygotic.
ƒ?óDefined according to the clinical history and current definition, two fasting glucose measurements above 126 mg/dL (7.0 mmol/L).
¶õDefined as elevated concentrations of any or all of the lipids in the plasma, according to the clinical history.